Showing 1241-1250 of 3009 results for "".
The Effects of Climate Change on Emerging Infections and the Global Landscape of Neuroinfectious Disease
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-effects-of-climate-change-on-emerging-infections-and-the-global-landscape-of-neuroinfectious-disease/32155/Climate change has direct and indirect effects that have altered the landscape of neuroinfectious disease and will continue to do so.Headache in Men
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-in-men/32000/Migraine and cluster headache present differently in men than women with important implications for care management.Treatment of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/treatment-of-functional-movement-disorder/31885/All members of the treatment team must provide a unified message to a patient with functional movement disorder for treatment success.Emerging Therapies to Slow the Progression of Huntington Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-therapies-to-slow-the-progression-of-huntington-disease/31936/Although clinical trial results have been disappointing, they have moved development of potential disease-modifying treatments forward.Spontaneous Intracranial Hypotension
https://practicalneurology.com/diseases-diagnoses/headache-pain/spontaneous-intracranial-hypotension-1/31656/Spontaneous intracranial hypotension requires a high index of suspicion because of potentially normal diagnostic test results and refractory symptoms.Spotlight on Sleep: Beyond the Polysomnogram—Modern Approaches to Diagnosing Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/beyond-the-polysomnogram-modern-approaches-to-diagnosing-sleep-apnea/35814/The evolution from in-laboratory polysomnography to flow-based home sleep apnea testing and, more recently, wearables reflects advancements in sleep technologies and a move toward patient-centered care.Clinical Biomarker Testing for Alzheimer Disease Pathology in the Context of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-biomarker-testing-for-alzheimer-disease-pathology-in-the-context-of-amyloid-targeting-treatments/67050/As blood-based biomarkers become integrated into routine practice, selecting the right test and understanding its limitations have become essential for accurate Alzheimer disease diagnosis and timely access to treatment.Advance Care Planning in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/advance-care-planning-in-amyotrophic-lateral-sclerosis/31809/Focusing on feelings, facts, and family is useful in shared decision making.Therapeutic Approaches to Neuromuscular Repeat Disorders: Facioscapulohumeral Muscular Dystrophy and Myotonic Dystrophy Type 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/therapeutic-approaches-to-neuromuscular-repeat-disorders-facioscapulohumeral-muscular-dystrophy-and-myotonic-dystrophy-type-1/32027/A promising pipeline of therapeutics target toxic RNA.Contemporary Challenges in the Recognition, Diagnosis, and Management of Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/contemporary-challenges-in-the-recognition-diagnosis-and-management-of-progressive-multiple-sclerosis/31974/There are many challenges associated with identifying the transition to secondary progressive multiple sclerosis.